SVB Securities and RBC Capital are acting as joint book running managers for the offering.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on AVTX:
- Avalo Therapeutics, Inc. Announces Pricing of $15 Million Public Offering of Common Stock and Warrants
- Avalo Therapeutics, Inc. Announces Proposed Public Offering of Common Stock and Warrants
- Avalo Therapeutics announces common stock, warrants offering
- Avalo Therapeutics completes target enrollment in Phase 2 PEAK trial
- Avalo Announces it Has Completed Targeted Enrollment of 80 Patients in Phase 2 PEAK Trial of AVTX-002 in Non-Eosinophilic Asthma